How Aldevron and Oxford Genetics have come together to advance CAR-T development.
By James Brown, VP Corporate Development, Aldevron
White Paper: Advancing Next Generation Therapeutics
By Sartorius brands; IncuCyte & intellicyt
How to Generate Optimal-Affinity TCRs for the Clinic?
By Elisa Kieback, CEO, T-Knife
Development of First Manufacturing Process to Produce CAR-Treg Cells for Clinical Use
By Pierre Heimendinger, VP Pharmaceutical Development, TxCell
Regenerative Medicines and Cell Therapy Products: Is the NICE Therapy Products: Is the NICE Therapy
By Grace Hampson, Senior Economist, The Office of Health Economics